Judge Decertifies Class In Off-Label Neurontin Suit
A Philadelphia judge has decertified a class in a putative action against Pfizer Inc. over off-label marketing of generic versions of its blockbuster epilepsy drug Neurontin, finding that the class members'...To view the full article, register now.
Already a subscriber? Click here to view full article